| Name | Title | Contact Details |
|---|---|---|
Mike Hull |
Sr. Customer Success Director, CS Enablement /Tech and Telecom Team | Profile |
Alexis Kitchen |
Director of Product Operations | Profile |
David Kiszka |
Sr. Customer Success Director | Profile |
Lynsie Sutton |
Senior Customer Success Director, BPO | Profile |
Marty Pankau |
Chief Customer Officer | Profile |
At parcelLab, we give people new reasons to fall in love with brands, by unlocking a whole new part of the customer journey, to bring people and brands closer together. Our branded communications give businesses over 30 million new opportunities to connect with their customers, every single day. For brands, that means more chances to create relationships that last. And for the people that buy from them, it means turning mundane operational processes into moments of joy. All of those happy moments add up to bring people and brands closer together. For customers that keep coming back, again and again.
PowerReviews works with more than 1,000 global brands and retailers to deliver cloud-based software that collects and displays ratings and reviews and questions and answers on websites. Ratings and reviews solutions from PowerReviews are essential for consumers as they search and shop online and in-store, and they are proven to increase online site-wide sales.
PinkLion assembles AI tools into custom subscription bundles for enterprise app teams.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
ARM Associates is a Waltham, MA-based company in the Software and Internet sector.